Beijing Sunho Pharmaceutical Co (BJSE:430017) Change In Working Capital : ¥0.0 Mil (TTM As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Beijing Sunho Pharmaceutical Co Change In Working Capital?

Beijing Sunho Pharmaceutical Co's change in working capital for the quarter that ended in Jun. 2024 was ¥0.0 Mil.

Beijing Sunho Pharmaceutical Co's change in working capital for the fiscal year that ended in Dec. 2022 was ¥-29.9 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Beijing Sunho Pharmaceutical Co Change In Working Capital Historical Data

The historical data trend for Beijing Sunho Pharmaceutical Co's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Sunho Pharmaceutical Co Change In Working Capital Chart

Beijing Sunho Pharmaceutical Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Working Capital

Get a 7-Day Free Trial

-9.44

85.18

-85.06

13.57

-29.90

Beijing Sunho Pharmaceutical Co Quarterly Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Change In Working Capital	Get a 7-Day Free Trial															-	-	-	-	-

Beijing Sunho Pharmaceutical Co Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

Beijing Sunho Pharmaceutical Co Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Beijing Sunho Pharmaceutical Co's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Sunho Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Sunho Pharmaceutical Co Ltd (BJSE:430017) » Definitions » Change In Working Capital

Traded in Other Exchanges

N/A

Address

No. 18, Zhonghe Street, Beijing Economic and Technological Development Zone, Beijing, CHN, 100176

Website

http://www.sunho.com.cn

Beijing Sunho Pharmaceutical Co Ltd engages in the research and development, production, and sales of pharmaceutical preparations while providing CMC/CMO integrated services for pharmaceutical preparation manufacturers and innovative drug R&D enterprises. The company produces small-volume injections, freeze-dried powder injections, hard capsules, tablets, and other products.

Beijing Sunho Pharmaceutical Co Headlines

No Headlines